| Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model | Pharmaceutics |  | | 2024 | 127 | 259 |
|
| Challenges and Opportunities in the Oral Delivery of Recombinant Biologics | Pharmaceutics | | | 2023 | 50 | 62 |
|
| Nanofitin as a novel shuttle for oral delivery of biologics | |  | | 2022 | 654 | 15 |
|
